ALVO · Alvotech
United States · RS rating 56 · As of 2026-11-03
| Price | 4.54 USD |
|---|---|
| 1-day change | +1.3% |
| RS rating (overall / 1M / 3M / 12M) | 56 / 16 / 90 / 25 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 27 / 22 / 8 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +46.5% |
| Distance from 52-week high | +26.2% |
| Market cap (USD) | $1.1B |